risks associated with semaglutide Wegovy may raise risk of ischemic optic neuropathy 👁️ The obesity drug semaglutide, marketed as Wegovy, was a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic Semaglutide GLP-1 Injections for Weight

Plan around your injection day At 50 units (especially at higher mg doses), the day of injection and the following day may bring stronger side effects

As such, the FDA warns that Ozempic, Rybelsus, and Wegovy should not be used by those with a family history of medullary thyroid carcinoma or a personal history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Soluble fiber: the gel formers Soluble fiber dissolves in water

Allies in the Trump administration As the battle over GLP-1s rages on, some compounding pharmacies are amassing power and resources

Despite the lower weight loss cost, the drug has been shown to be far less effective than semaglutide variants